Facultative role for T cells in extrafollicular Toll-like receptor-dependent autoreactive B-cell responses in vivo by Sweet, Rebecca et al.
Facultative role for T cells in extrafollicular Toll-like
receptor-dependent autoreactive B-cell responses
in vivo
Rebecca A. Sweeta,b, Michelle L. Olsb, Jaime L. Cullenb, Ashley Viehmann Milama, Hideo Yagitac, and
Mark J. Shlomchika,b,1
Departments of aImmunobiology and bLaboratory Medicine, Yale University School of Medicine, New Haven, CT 06520; and cDepartment of Immunology,
Juntendo University School of Medicine, Tokyo, Japan
Edited* by Michael B. Brenner, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, and approved April 1, 2011 (received for review
December 13, 2010)
Extrafollicular (EF) B-cell responses are increasingly being recog-
nized as an alternative pathway of B-cell activation, particularly in
autoimmunity. Critical cellular interactions required for the EF B-
cell response are unclear. A key question in autoimmunity, in
which Toll-like receptor (TLR) signals are costimulatory and could
be sufficient for B-cell activation, is whether T cells are required for
the response. This is pivotal, because autoreactive B cells are
considered antigen-presenting cells for autoreactive T cells, but
where such interactions occur has not been identified. Here, using
AM14 site-directed transgenic rheumatoid factor (RF) mice, we
report that B cells can be activated, differentiate, and isotype-
switch independent of antigen-specific T-cell help, αβ T cells,
CD40L signaling, and IL-21 signaling to B cells. However, T cells
do dramatically enhance the response, and this occurs via CD40L
and IL-21 signals. Surprisingly, the response is completely inducible
T-cell costimulator ligand independent. These results establish
that, although not required, T cells substantially amplify
EF autoantibody production and thereby implicate T-independent
autoreactive B cells as a potential vector for breaking T-cell toler-
ance. We suggest that these findings explain why autoreactivity
first focuses on self-components for which B cells carry TLR
ligands, because these will uniquely be able to activate B cells
independently of T cells, with subsequent T–B interactions activat-
ing autoreactive T cells, resulting in chronic autoimmunity.
systemic lupus | autoantibodies
Although much attention has been recently focused on thegerminal center (GC) reaction—which creates long-lived
memory and plasma cells—some B-cell responses engage pri-
marily the extrafollicular (EF) pathway of activation (1). This
response occurs predominantly in the marginal sinus bridging
channels at the border of the T-cell zone and red pulp, spilling
into the adjacent red pulp areas. These locations are rich in
dendritic cells and other myeloid cells but lack follicular den-
dritic cells. EF responses rapidly generate large numbers of
short-lived plasmablasts. The location and cell types inherent in
the EF response suggest that it may be regulated quite differently
from the GC response and may generate different cellular
products with different biological implications. The EF pathway
is seen transiently in T cell-dependent responses to protein
antigens (Ags) (1) and more recently has been appreciated as
a major and sometimes sustained component of pathogen
responses, particularly to bacteria (2, 3).
Despite its likely importance in immunity, many aspects of the
EF response remain poorly defined. For example, the roles of T
cells in the EF response are not clear. The EF response is
thought to undergo minimal, if any, somatic hypermutation of Ig
variable regions in responding cells and similarly to have little
isotype switch (1). Mutation and switch are often thought to rely
on T-cell signals, yet it remains poorly defined whether these
processes are influenced by T cells in the EF response. In this
connection, immunization with T-independent Ags induces
a robust but transient and largely unswitched EF response,
suggesting that T cells are not required (4).
Recently, it has become apparent that autoantibody responses
also proceed through the EF pathway (5, 6). Evidence for this
comes from multiple mouse systems and can be inferred from
the production of plasmablasts and short-lived autoantibody
responses in humans (5, 7–9). It seems that a prominent re-
quirement for systemic autoimmune EF responses is that the
self-Ag contain a Toll-like receptor (TLR) ligand that is recog-
nized by a B cell-intrinsic TLR. Indeed, targets of autoantibodies
such as DNA, RNA, and self-IgG [in this case as immune
complexes (ICs) with IgG antinuclear Abs] do contain TLR
ligands. Conversely, when an artificial Ag is provided with
a TLR9 ligand, it engages a predominantly EF response (10).
The identification of a TLR-driven EF-based activation of
autoreactive B cells has broad implications for understanding the
mechanisms that initiate and propagate B-cell autoimmunity,
most of which have yet to be fully explored. For example, acti-
vation of autoreactive B cells at EF sites promotes disease by
generating pathogenic autoantibodies as well as activated B cells
that in turn can mediate damage by Ab-independent mecha-
nisms, in particular by promoting autoreactive T-cell activation
(11). Therefore, it is critical to understand the cellular inter-
actions and signals that are required for and control EF
responses in autoimmunity, because any of these could be
therapeutic targets.
Given the pivotal nature of breaching T-cell tolerance in the
establishment of chronic autoimmunity, it is important
to determine whether EF responses in autoimmunity involve T
cells, and if so, to understand how these interactions take place.
We have been using AM14 B-cell receptor (BCR) transgenic
(Tg) mice (AM14), specific for self-IgG2a of the “a” allotype
[rheumatoid factor (RF) specificity], to study spontaneous and
induced RF responses that both use the EF pathway (5, 12).
AM14 B cells are activated by IgG2a antichromatin in vitro and
in vivo in a TLR-dependent fashion (13, 14). In vitro and pre-
sumably in vivo the antichromatin Abs complex with ubiquitous
chromatin released from dying cells, forming antigenic chroma-
tin-containing ICs. In vivo, IgG2a antichromatin stimulates
a robust EF response without evident GCs that depends on a
combination of TLR7 and TLR9 and requires MyD88 expression
in the B cell (14).
When studying only IgM responses in conventional IgM BCR
Tg mice, we found that induced plasmablast responses were of
normal magnitude in a T cell-deficient MRL/lpr background (14).
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However, larger numbers of somatic mutation in T-sufficient
contexts suggested that T cells could influence the response.
Nonetheless, direct evidence for T–B collaboration in this system
was lacking, and the signals involved were unknown. To de-
termine whether T cells do indeed affect the response, and if so
how, we have used a new AM14 BCR site-directed (sd)-Tg mouse
model, which can undergo isotype switch, as well as a BALB/c
background to eliminate confounding influences of the autoim-
mune milieu (15). Using a combination of genetic and inhibitor
approaches, we have found that the TLR-dependent EF auto-
antibody response in this model can indeed proceed to comple-
tion in the absence of T cells, including plasmablast differenti-
ation and isotype switch. However, we also found that Ag-specific
T cells can greatly augment the response. This occurs in a CD40L
and IL-21–dependent fashion but is inducible T-cell costimulator
ligand (ICOSL) independent. This indicates that the response
can initiate without T cells but that the EF response is none-
theless an important site for T–B collaboration in the generation
of classic autoantibodies. This has important implications for
understanding how autoimmunity initiates, as well as for how to
block it.
Results
Effects of T Cells Restricted to an Irrelevant TCR on the EF RF
Response. T cells can provide help to B cells in an Ag-specific or
nonspecific manner (16). We tested the requirement for Ag-
specific T-cell help by transferring AM14 sd-Tg BALB/c B cells
into DO11.10+/+ TCRα−/− BALB/c mice. In these experiments,
nearly all T cells in the mice were specific only for an ovalbumin
peptide and thus should not be able to help AM14 B cells in their
response to antichromatin Abs. The presence of T cells of an
irrelevant specificity preserved lymphoid architecture and con-
trolled for nonspecific effects of the absence of T cells. In the
AM14 sd-Tg mice a small subset of B cells expressing certain
Vκ8 family L chains recognizes self-IgG2a, and we identify these
cells using the 4–44 antiidiotype Ab (5, 17). In both DO11.10+/+
TCRα−/− BALB/c and WT recipients, the transferred 4–44+
AM14 B-cell population expanded in response to the IgG2a
antichromatin Ab, PL2-3, at day 6, as detected by flow cytometry,
but not if Ag was not given. However, PL2-3–induced expansion
of 4–44+ AM14 B cells was decreased approximately fourfold in
the DO11.10 BALB/c recipients compared with WT recipients
(Fig. 1A, Upper, and 1B). Antigen-specific division of 4–44+ cells
in both DO11.10 and WT recipients in response to PL2-3 was
detectable using dilution of carboxyfluorescein succinimidyl ester
(CFSE). However, proliferation of 4–44+ cells was decreased in
DO11.10 recipients compared with WT recipients, as shown by
an increased fraction of undivided 4–44+ cells in the PL2-3–
treated DO11.10 mice (Fig. 1A, Lower, and 1C). Similarly, both
WT and DO11.10 recipients were permissive for 4–44+ Ab-
forming cell (AFC) differentiation. However, the generation of
both IgM and IgG2a 4–44+ AFC populations was reduced in
DO11.10 recipients compared with WT recipients (Fig. 1 D and
E), with IgG2a being somewhat more affected than IgM.
DO11.10 mice have a stable, albeit smaller, CD4 T-cell com-
partment (Fig. S1A). This provided normal lymphoid architec-
ture in DO11.10 recipients to host EF plasmablast responses
similar to those found in WT recipients (Fig. S1B). Thus, by all
parameters analyzed, lack of specific T-cell help does not elim-
inate the ability of 4–44+ cells to respond. However, specific T-
cell help has a role in optimizing 4–44+ B-cell proliferation
and differentiation.
Effects of T-Cell Deficiency on the EF RF Response. Although in-
dicating a role for Ag-specific T-cell help, the prior experiment
does not eliminate the possibility that T cells could also be
helping B cells to initiate the response in a nonspecific manner.
If T cells also had a nonspecific role, elimination of all T cells
would abrogate the response. To test this, we transferred AM14
sd-Tg BALB/c B cells into TCRα−/− BALB/c mice, which lack all
αβ T cells, or into control BALB/c mice. We then activated the
AM14 B cells with PL2-3 and analyzed the response at day 5.
The expansion of 4–44+ B cells was comparable in TCRα−/−
mice compared with WT controls (Fig. 2A, Upper, and 2B).
Similarly, IgD down-regulation was comparable between the two
groups of mice (Fig. 2A, Lower, and 2C). The 4–44+ IgM AFC
numbers were also not different between WT and TCRα-
deficient mice (Fig. 2D). In contrast, numbers of 4–44+ IgG2a
AFCs were reduced ≈2.5-fold in TCRα−/− mice, although still
substantial in quantity compared with the unimmunized TCRα−/−
controls (Fig. 2E). These results indicate that αβ T-cell help is not
required for initiating the AM14 B-cell response to PL2-3, but
such T cells optimize the differentiation of IgG2a AFCs. There is
therefore no evidence of a nonspecific effect of T-cell help. If T
cells were providing help nonspecifically, we would have found
a lower response in the fully αβ T cell-deficient animals; if any-
Fig. 1. Specific T-cell help is not required for but enhances the RF B-cell re-
sponse to IgG2a antichromatin Abs. BALB/c or DO11.10 TCR Tg,TCRα-deficient
BALB/c mice were killed on day 6, and splenocytes were analyzed after
transfer of purified AM14 sd-Tg B cells and administration of PL2-3 as in-
dicated in Materials and Methods. (A) Representative flow cytometry plots
are shown for mice in treatment groups, as indicated for both rows. Upper:
Live events. Lower: 4–44+ events. (A, Upper, and B) 4–44+ surface and in-
tracellular double-positive cells were quantitated. (A, Lower, and C) Pro-
liferation was assessed using CFSE dilution with 4–44+CFSEhi cells considered
to be undivided. (D and E) Splenic 4–44+ AFCs of IgM (D) or IgG2a (E) isotype.
Data are compiled from two independent experiments. **P < 0.01, Mann-
Whitney two-tailed test.
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thing, the response is more robust in the mice lacking such cells
compared with the T cell-restricted animals.
These results clearly show that Ag-specific T cells are not re-
quired to initiate the EF AM14 B-cell response to antichromatin
Abs in vivo. Proliferation and differentiation were both observed
in the absence of Ag-specific T-cell help. However, T cells do
seem to have a role in supporting the amplification of the EF B-
cell response because the response was quantitatively diminished
in the absence of T cells. Further, we infer that Ag-specific T-cell
help is required for an optimal response, because an environ-
ment containing nonspecific T-cell help (Fig. 1) did not augment
the AM14 B-cell response at all compared with an environment
lacking αβ T cells (Fig. 2). The magnitude of the control
responses was somewhat smaller in these experiments compared
with those in Fig. 1, which we attribute to a different lot of Ag as
well as a 1-d difference in the duration of the response. It is not
clear why the reduction of AM14 B-cell response to anti-
chromatin antibodies in DO11.10 recipients was more robust
compared with the reduction seen in αβ T cell-deficient mice.
DO11.10 mice contain Treg (Fig. S1A), and these may regulate
the AM14 B-cell response in an Ag-nonspecific way.
Molecular Mechanisms of T-Cell Help for the EF Response. To in-
vestigate mechanisms by which Ag-specific T cells help EF B
cells, we tested three components of T-cell help: CD40L sig-
naling, IL-21 secretion, and ICOS signaling. All of these are
known to be important for the generation and maintenance of
the GC pathway (18, 19), but none has been tested in vivo in this
type of autoreactive EF response.
To test the role of CD40L in PL2-3 induction of AM14 B-cell
activation, we used the blocking Ab MR-1 (20), comparing it
with a hamster IgG control. CD40L was blocked before and
during PL2-3 activation of transferred AM14 sd-Tg BALB/c B
cells in BALB/c mice, and the response was observed at day 5
after activation. Expansion of the 4–44+ population was ob-
served in both groups but was suboptimal in mice treated with
MR-1 (Fig. 3A). Within the 4–44+ population, a similar pro-
portion of cells had down-regulated IgD in both groups (Fig.
3B). The 4–44+ IgM AFC population was also comparable in
both groups (Fig. 3C). In contrast, CD40L-blockade reduced the
frequency of 4–44+ IgG2a AFCs that developed in response to
PL2-3 (Fig. 3D). Thus, CD40L interactions are important for
optimizing the AM14 B-cell response to PL2-3.
IL-21 secreted by T follicular helper (TFH) cells has been
shown to support GC responses (18). Most pertinent to the
AM14 response to antichromatin Ab, a subset of T cells that
resembles TFH has been identified by FACS and histology to be
located in the EF regions of diseased MRL/lpr and other auto-
immune-prone mice (21). These EF T cells express ICOS and
Fig. 2. αβ T cells are not required for but enhance the RF B-cell response to
IgG2a antichromatin Abs. BALB/c or TCRα-deficient BALB/c mice were killed
on day 5, and splenocytes were analyzed after cell transfer of purified AM14
sd-Tg B cells and administration of PL2-3. (A) Representative flow cytometry
plots are shown for treatment groups as indicated and are gated as de-
scribed in Fig. 1A. (A, Upper, and B) 4–44+ surface and intracellular double-
positive cells. (A, Lower, and C) Fraction of 4–44+ cells that had lost ex-
pression of IgD. (D and E) Splenic 4–44+ AFCs of IgM (D) or IgG2a (E) isotype.
Data are compiled from four independent experiments. *P < 0.05, Mann-
Whitney two-tailed test.
Fig. 3. Blocking CD40L only partially inhibits the RF B-cell response to IgG2a
antichromatin Abs. BALB/c mice were killed on day 5 after cell transfer with
CD40L blocking and PL2-3 as indicated. (A) 4–44+ surface and intracellular
double-positive cells. (B) Fraction of 4–44+ cells that had lost expression of
IgD. (C and D) Splenic 4–44+ AFCs of IgM (C) or IgG2a (D) isotype. Data are
compiled from three independent experiments. *P < 0.05 and **P < 0.01,
Mann-Whitney two-tailed test.









have down-regulated PSGL1, much like TFH cells, but express
CXCR4, unlike TFH. Notably, they secrete IL-21, which can in
turn promote in vitro B-cell isotype switch. Given the evidence
for a role of Ag-specific T cells in promoting the EF response to
antichromatin, we wanted to determine whether IL-21 signaling
in the B cell was important for the antichromatin-driven EF
response. To test this, we transferred IL-21R−/− AM14 sd-Tg
BALB/c B cells or WT AM14 sd-Tg BALB/c B cells into WT
BALB/c recipients and administered PL2-3. Although both types
of AM14 B cells expanded in response, IL-21 receptor deficiency
on the transferred AM14 B cells resulted in a 2.5-fold less ex-
pansion compared with the WT AM14 B cells (Fig. 4A). Cells
differentiating toward the plasmablast fate can be identified as
CD22lo and CD44hi (5). The proportion of the 4–44+ cells that
became CD22lo and CD44hi in response to PL2-3 was equal in
both WT and IL-21R–deficient AM14 B cells (Fig. 4B), in-
dicating that IL-21 signals in the B cell were not required for
initial differentiation toward the plasmablast lineage. We ob-
served 4–44+ AFCs that were IgM and IgG2a in both groups.
However, the AFC response was not as large when AM14 B cells
lacked the IL-21R, with approximately a sixfold decrease in the
frequency of IgG2a AFCs and a fourfold decrease in the fre-
quency of IgM AFCs (Fig. 4C). Interestingly, in both cases there
were comparable populations of 4–44+ IgG2b AFCs, whereas
the 4–44+ IgA AFCs were increased, and the 4–44+ IgG3 AFCs
were decreased (Fig. 4D), showing that IL-21 affects only some
isotypes. Thus, IL-21 has a direct influence on the later stages of
B-cell differentiation, affecting isotype switch and plasmablast
maturation to the AFC stage.
Because ICOS is up-regulated on TFH cells, it is important to
know whether T cells that augment the EF response require
ICOS signaling to function. To assess this, B cells were isolated
from AM14 sd-Tg BALB/c mice and transferred to BALB/c
recipients and activated with PL2-3. These mice were injected
with HK5.3 antibody to block ICOSL (22). Because ICOS is not
up-regulated until after T-cell activation, the first injection was
given on day 2. The 4–44hi population increased in both PL2-3–
treated groups of mice regardless of ICOSL blocking (Fig. 5 A and
B), a reflection of Ag-driven activation. The proportion of the
4–44+ population that had down-regulated IgD was also equiva-
lent in both groups (Fig. 5C). We examined four different isotypes
of 4–44+ AFC in response to PL2-3: IgM, IgG2a, IgG2b, and IgA.
Across all isotypes, there was no change in 4–44+ AFC production
(Fig. 5 D–G). Equivalent 4–44+ plasmablast and AFC responses
were also observed in ICOSL Ab or control-treated intact AM14
sd-Tg BALB/c mice (Fig. S2). ICOSL blocking capability was
validated because we observed a substantial reduction of GCs in
response to NP-chicken gamma globulin (NP-CGG) in alum both
by flow cytometry and immunofluorescence histology (Fig. S3).
These data show that ICOS signaling is not required for initial EF
RF B-cell activation and differentiation.
Discussion
T cells have been observed at the EF site (23, 24), but their role
in defined EF B-cell responses has not been clear. Our data
show, using multiple systems and approaches to block T cells,
that they are not required for the complete maturation of the EF
response. However, at a quantitative level, T cells contribute
substantially, enhancing the response, for example by augment-
ing the 4–44+ IgG2a+ AFC response on the order of sixfold (Fig.
1E). Over the course of time in a setting of spontaneous and
chronic autoreactive B-cell activation, the enhancement pro-
vided by T cells would be quite substantial. Indeed, disease is
reduced in lupus-prone mice deprived of T cells from birth or
treated chronically with T-depleting Abs (25, 26) (although it
should be noted that these mice do make some autoantibodies).
Fig. 4. Deficiency of IL-21R reduces class switch to IgG2a. On day 0, 8 million AM14 sd-Tg or AM14 sd-Tg.IL-21R KO B cells were purified (88–90% purity) and
transferred into CD45.1 BALB/c recipients. Mice were either left untreated or injected with PL2-3. On day 6, splenocytes were assayed by flow cytometry to
detect the 4–44+ population (A) and CD22lo CD44hi plasmablasts within the 4–44+ population (B). (C) Splenic 4–44+ AFCs of IgM or IgG2a; and (D) IgG2b, IgA,
or IgG3 isotypes. Data are compiled from three independent experiments. *P < 0.05; ***P < 0.001; ****P < 0.0001, Mann-Whitney two-tailed test.
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It seems likely that B cells activated by TLR ligand-containing
self-Ag must interact with and activate T cells to fully expand and
maintain the response. Once such a T–B collaborative amplifying
loop is established, the response could become self-sustaining,
leading to chronic autoimmunity (27).
The experiments described here provide important insights
into the influence of T cells on the development of an autor-
eactive B-cell response. First, we found that specific T cells are
required; AM14 B cells responded similarly whether T-cell help
was of an irrelevant specificity or completely absent. Second, we
observed that CD40L is an important ligand in the process,
further implicating T cells and strongly suggesting the need for
a cognate interaction between T and B cells. Third, IL-21, al-
though not essential—as with other T-cell signals—influences
the response in both quantitative and qualitative fashions (pro-
moting IgG2a and IgG3 switching) via its direct action on
responding B cells. IL-21 has previously been implicated in
contributing to murine models of autoimmune disease, pre-
sumably via multiple effects on T and B cells (28); here we define
a specific influence directly on the autoreactive B cell. Taken
together, we conclude that Ag-specific T cells optimize the
AM14 B-cell response to PL2-3 in vivo through CD40L and IL-
21 but are not required for either initiation or completion of
differentiation to the plasmablast stage (Fig. S4).
This work also provides an in vivo link to T EF helper cells first
characterized by Odegard et al. (21) that produce IL-21 and can
promote plasmablast expansion and switching in vitro. Although
ICOS is required for the development of T EF helper cells in
chronically autoimmune mice, our data support an ICOS-
independent mechanism in helping B cells during their initial
activation and differentiation. This supports earlier work impli-
cating a requirement for ICOS in B-cell responses to protein Ag
but not polysaccharide Ag (29). Our data support the idea that
the requirements for effective T-cell help adapt depending on
the nature and the persistence of the Ag. In systemic autoim-
munity, Ag is constitutively generated from dying cells. This may
allow synergy of BCR with TLR signaling to bypass the re-
quirement for ICOS.
The requirement for specific T cells does raise an important
unanswered question: what is the nature of the auto-Ag(s) for
these T cells? There is no obvious foreign Ag being introduced
when PL2-3, a syngeneic IgG2a purified from syngeneic animals,
is introduced. Presumably T cells are activated that recognize
self-Ag in the chromatin-containing IC and/or the self-IgG. De-
spite expectations of self-tolerance, several groups have shown
that chromatin or splicesome protein-specific T cells do exist in
the periphery of normal animals and that they can be activated,
particularly when specific B cells present Ags (30, 31). Similarly,
T cells specific for self-IgG have been described (32). It will be of
great interest to identify the specificities and types of T cells that
are providing help to the pathogenic EF response.
In general, the emphasis on “T-dependent” vs. “T-independent”
responses in classical model systems may have clouded the issue of
what happens in a more physiological setting with biologically
relevant Ags. In our case, we have used an Ag relevant to the
production of both RF and antichromatin Abs in vivo. This Ag has
some characteristics of a T-independent type 1 Ag, with a TLR
ligand and possibly an enhanced ability to crosslink the BCR given
the multivalent nature of ICs and also of chromatin itself (14).
Notably, pathogens, such as bacteria and viruses, would share
many of these properties, although whether they are able to ac-
tivate B cells in an analogous way remains unclear (33). With such
Ags, the simple concepts of “T-dependent” or “T-independent”
are inadequate to describe the in vivo interactions that control the
EF B-cell response, and this is where the present work provides
important insights. Our data demonstrate that all aspects of the
response can and do happen in the absence of T cells, including
expansion, differentiation, and isotype switch [mutation was also
previously demonstrated (14)]. The significant implication of this
observation is that self-reactive B cells can be activated all of the
way to effector function without the need to break T-cell toler-
ance. We propose, therefore, that expression of nucleic acid-spe-
cific TLRs by B cells is a weak link in the systems that prevent
autoreactivity but has been evolved as a result of the benefit from
enhanced responses to microbial pathogens. Self-Ags that provide
a TLR ligand will have a differentially greater ability to activate B
cells in the absence of T-cell help, and this program of activation
leads much further than previously thought. We suggest that this
TLR requirement explains why antinuclear Abs are a final com-
mon outcome of many immune dysregulatory disorders, and
Fig. 5. Blocking ICOSL does not inhibit the RF B-cell response to IgG2a
antichromatin Abs. BALB/c mice were killed on day 6 after transfer of AM14
sd-Tg B cells and administration of PL2-3 along with ICOSL blocking or
control Ab. Representative flow cytometry plots are shown, gated as de-
scribed in Fig. 1A. (A and B) 4–44+ surface and intracellular double-positive
cells. (C) Fraction of 4–44+ cells that had lost expression of IgD. (D–G) Splenic
4–44+ AFCs of IgM (D), IgG2a (E), IgG2b (F), or anti-IgA (G) isotype. Data are
compiled from two independent experiments.









indeed, the EF pathway of activation is being identified in a variety
of systems with B-cell autoimmunity (8, 27, 34).
Materials and Methods
Mice. AM14 sd-Tg BALB/c mice were generated as previously described (15).
BALB/c mice were purchased from Jackson Laboratories. DO11.10 Tg TCRα−/−
and TCRα−/− BALB/c mice were obtained from Dr. Kim Bottomly (Yale Univer-
sity, New Haven, CT) (35). IL-21R−/− BALB/c mice (36) were obtained from
Dr. Warren Leonard (National Institutes of Health, Bethesda, MD). CD45.1
BALB/c mice were obtained from Dr. Hyam Levitsky (Johns Hopkins School
of Medicine, Baltimore, MD). All mice were maintained at Yale University
School of Medicine under specific pathogen free conditions and used accord-
ing to Institutional Animal Care and Use Committee-approved protocols.
B-Cell Isolation and Adoptive Transfer. Splenic B cells were prepared using the
EasySepMouse B Cell Enrichment kit (Stemcell Technologies) according to the
manufacturer’s instructions, resulting in purity of 95% or greater as de-
termined by FACS, unless otherwise indicated. Three million B cells in PBS
were injected i.v. per mouse, unless otherwise indicated.
Ascites Preparation and Immunization. PL2-3 hybridoma was grown and Ab
was obtained as previously described (12). PL2-3 (500 μg) was administered to
animals i.p. on days 0, 2, and 4.
CFSE Labeling. Primary cells were cultured at 37° for 10 min in the dark with
10 μM CFSE (Invitrogen) in PBS with 0.1% BSA.
Blocking Antibodies. To block CD40L, MR-1 mAbwas purified from serum-free
tissue culture supernatant using Protein G sepaharose (Pharmacia) as pre-
viously described (17). Two hundred micrograms in sterile PBS was injected
i.p on days −1 and 2. To block ICOSL, 200 μg HK5.3 mAb (22) in sterile PBS
was injected i.p. on days 2 and 4.
Flow Cytometry. Cell preparation and staining was performed as previously
described (17). Dead cells were excluded using ethidium monoazide staining.
Abs were made in the laboratory as previously described (17) or purchased
from vendors as indicated. The following staining reagents were used for
these experiments: 4–44 (AM14 anti-Id)-biotin, 4–44 Alexa-647, anti-CD4
Pacific Blue (GK1.5), anti-CD22 PE (Cy34.1; BD), anti-CD25 PE (7D4; Southern
Biotech), anti-CD44 Alexa 488 (IM7), anti-CD45 Alexa 488 (6B2), anti-CD95 PE
(Jo2; BD), anti-FoxP3 APC (FJK-16s; eBioscience), anti-IgD FITC (11-26c.2a;
Biolegend), anti-TCR β biotin (H57-597; BD), PNA biotin (Vector Laborato-
ries), and streptavidin (SA) PE-Cy7 (BD).
Samples were analyzed on an LSRII (BD). Data were analyzed with
FlowJo software.
ELISpot Assay. ELISpot assay was performed and analyzed as previously de-
scribed (12). Goat anti-Ig isotype coating Abs were purchased from
Southern Biotech.
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